Edition:
United States

Cardiovascular Systems Inc (CSII.OQ)

CSII.OQ on NASDAQ Stock Exchange Global Select Market

23.74USD
30 Sep 2016
Change (% chg)

$0.89 (+3.89%)
Prev Close
$22.85
Open
$22.90
Day's High
$23.81
Day's Low
$22.88
Volume
141,843
Avg. Vol
118,502
52-wk High
$25.21
52-wk Low
$7.50

CSII.OQ

Chart for CSII.OQ

About

Cardiovascular Systems, Inc. is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary artery diseases, including those with arterial calcium. The Company develops an orbital atherectomy technology for both peripheral and coronary commercial applications. Its peripheral... (more)

Overall

Beta: 1.38
Market Cap(Mil.): $761.95
Shares Outstanding(Mil.): 33.35
Dividend: --
Yield (%): --

Financials

  CSII.OQ Industry Sector
P/E (TTM): -- 37.20 36.83
EPS (TTM): -1.72 -- --
ROI: -45.12 12.50 13.93
ROE: -46.62 14.81 14.84

BRIEF-Cardiovascular Systems names Scott Ward as CEO

* Cardiovascular Systems Inc says Scott R. Ward, company's new chairman and chief executive officer, effective immediately

Aug 16 2016

BRIEF-Cardiovascular Systems reports Q4 loss per share $0.15

* Q4 earnings per share view $-0.20 -- Thomson Reuters I/B/E/S

Aug 03 2016

BRIEF-Cardiovascular Systems submits coronary orbital atherectomy system for approval in Japan

* Submits diamondback 360 coronary orbital atherectomy system micro crown for approval in japan

Jul 06 2016

BRIEF-Cardiovascular Systems sees Q4 2016 loss $0.18-$0.21/shr

* Cardiovascular Systems Reports Fiscal 2016 Third Quarter financial results

May 04 2016

Earnings vs. Estimates